Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel AR and CYP17A1 dual inhibitor shows significant antitumor activity

March 6, 2015

Phase II results presented for a urothelial carcinoma combination therapy

March 6, 2015

First-in-human MesomiR 1 study results confirm tolerability of TargomiRs

March 5, 2015

Innocrin Pharmaceuticals presents encouraging data for VT-464

March 5, 2015

Encouraging results seen with TRC-105 and axitinib in renal cell carcinoma trial

March 5, 2015

CTX conditioning maximizes SB-728-T engraftment

March 5, 2015

Addition of ipilimumab to Prostvac appears beneficial in treating prostate cancer

March 5, 2015

PSMA antibody-drug conjugate shows potential for the treatment of prostate cancer

March 4, 2015

Multiplatform tumor profiling shows potential for therapeutic decision-making

March 4, 2015

Envelope-specific monoclonal antibodies offer a novel approach for the treatment of HIV infection

March 3, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...